Description
ABT530 (Pibrentasvir) is an HCV NS5A inhibitor with EC50s ranging from 1.4-5.0 pM against HCV replicons containing NS5A from genotypes 1-6.
Molecular Formula
C57H65F5N10O8
Smiles
CO[C@H](C)[C@H](NC(=O)OC)C(=O)N1CCC[C@H]1C1NC2CC(F)C(CC2[NH]1)[C@H]1CC[C@@H](N1C1CC(F)C(N2CCC(CC2)C2CCC(F)CC2)C(F)C1)C1CC2[NH]C(NC2CC1F)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)[C@@H](C)OC
Storage
Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Solubility Information
DMSO: 50 mg/mL (44.92 mM), Sonication is recommended.
Relative Density
1.363 (Predicted)